Question-and-Answer Session
Operator
(Operator Instructions). Your first question comes from the line of Bret Holley with Oppenheimer & Co.
Bret Holley - Oppenheimer & Co
Congratulations on the approval.
Louis Lange
Thanks, Bret.
Bret Holley - Oppenheimer & Co
Hey, I just got a question about the relative timing of the partnership. It seems like to me the potential partner in Europe might want to be in place for discussion on negotiating pricing and that would suggest that sooner or later would be the time on the partnership. Can you just give me a little bit clearer view on that?
Louis Lange
Yeah, well Bret, well, the advantage we are having some the people, and we have four or five peoples in England on the ground is that we use the same agencies and consulting firms that they use and our people have been in many of the same company. So, that's not a big deal.
We have lots of interest on partnership whether it's global or EU. And I think the goal here is to maximize the outcome for the product and enhance our shareholders. So we're very confident about obtaining a partner. But I think we want to get the right deal.
Bret Holley - Oppenheimer & Co
Okay. And then, I guess along on those same lines, what is your current stance on the global versus just a European partnership given the approval yesterday?
Louis Lange
Yeah. Well, this is a multi-dimensional chess game with lots of apples, oranges and pears. And I think it's our job as the management team is to optimize the outcome and I would say it's too early to tell. It could be global, could be RW, it could be Europe. And, of course, it can come with pipeline support, development support and different flavor of commercialization support. And there are lots of opportunities today. So it will too early to pin us down yet on which one.
Bret Holley - Oppenheimer & Co
Okay. And a quick question for Dan, on the inventory side, what is your plan for managing that situation going forward? I mean. Do you have agreements, so you can control the inventory going forward for Ranexa in the U.S.?
Dan Spiegelman
We do have inventory agreements and they are operating within on the-- change from forward of three weeks as well within the contractual range. And that's just sort of the -- put life in that, [life] as being a drug company. They modulate those slightly.
- To read the full transcript on Seeking Alpha, click here »
